a public good project by the
Synthesis
Company
of California

© 2026

Giles Hellawell | doi.page

0 works0 citations0 h-index

Giles Hellawell

National Health Service(GB)Imperial College Healthcare NHS Trust(GB)Charing Cross Hospital(GB)Imperial College London(GB)

Publications by Year

Research Areas

Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Medical Imaging Techniques and Applications, Bladder and Urothelial Cancer Treatments, Colorectal Cancer Surgical Treatments

Most-Cited Works

→ MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis(2018)2,923 cited
Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.(2002)
→ RADIATION EXPOSURE AND THE UROLOGIST: WHAT ARE THE RISKS?(2005)165 cited
→ Use of [11C]Choline PET-CT as a Noninvasive Method for Detecting Pelvic Lymph Node Status from Prostate Cancer and Relationship with Choline Kinase Expression(2011)114 cited
→ Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer(2004)112 cited
→ Urology and the Internet: an evaluation of Internet use by urology patients and of information available on urological topics(2000)105 cited

→ Technique of Laparoscopic-Endoscopic Single-Site Surgery Radical Nephrectomy(2009)

96 cited

→ Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma(2015)82 cited

→ Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall(2014)65 cited

→ High dose rate prostate brachytherapy: an overview of the rationale, experience and emerging applications in the treatment of prostate cancer(2012)58 cited